Published in Int Ophthalmol on September 12, 2013
The role of heredity in pterygium development. Int J Ophthalmol (2014) 0.78
Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up. J Ocul Pharmacol Ther (2014) 0.78
Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye. Drug Des Devel Ther (2015) 0.77
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13. PLoS One (2017) 0.75
Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology (1997) 2.80
Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium. Ophthalmology (2006) 2.17
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci (2007) 2.05
Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis. Clin Experiment Ophthalmol (2007) 1.64
Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial. Cornea (2011) 1.55
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin). Br J Ophthalmol (2006) 1.48
Pterygium recurrence time. Ophthalmology (1994) 1.46
Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem (1996) 1.35
Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model. Am J Ophthalmol (2008) 1.19
Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2009) 1.18
Subconjunctival bevacizumab injection for corneal neovascularization. Cornea (2008) 1.16
Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium. Curr Eye Res (2008) 1.11
Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea (2001) 1.10
Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin). Cornea (2008) 1.10
Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium. Curr Eye Res (2010) 1.02
Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium. Cornea (2009) 1.00
Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 0.99
Effect of subconjunctival bevacizumab on primary pterygium. Cornea (2009) 0.98
Efficacy of intralesional bevacizumab injection in decreasing pterygium size. Cornea (2011) 0.95
Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization. Acta Ophthalmol (2008) 0.94
Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia. Med Hypotheses (2007) 0.94
Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmology (2005) 0.91
Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology (1995) 0.91
Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea (2003) 0.91
Treatment of inflamed pterygia or residual pterygial bed. Br J Ophthalmol (2009) 0.90
Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study. Cornea (2012) 0.88
Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs. Cornea (2008) 0.87
Scleritis associated with sarcoidosis. Ocul Immunol Inflamm (2004) 1.43
Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Acta Ophthalmol (2007) 1.39
Management of facial disfigurement in orbitotemporal neurofibromatosis. Ophthal Plast Reconstr Surg (2010) 1.39
Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf (2013) 1.25
Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS (2006) 1.15
Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients. Ophthalmology (2009) 1.15
Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol (2006) 1.08
Regression of neovascular posterior capsule vessels by intravitreal bevacizumab. J Cataract Refract Surg (2007) 1.04
Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation. Orbit (2010) 1.02
Nutrition assessment in critically ill patients. Nutr Clin Pract (2008) 0.98
Effect on astigmatism of the location of clear corneal incision in phacoemulsification of cataract. J Refract Surg (2007) 0.95
Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Cornea (2009) 0.94
Clinical factors associated with floppy iris signs: a prospective study from two centers. Ophthalmic Surg Lasers Imaging (2009) 0.94
Intravitreal injection of bevacizumab in Eales disease. Ocul Immunol Inflamm (2008) 0.93
Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography. Ocul Immunol Inflamm (2006) 0.91
Nasolacrimal duct obstruction: clinicopathologic analysis of 205 cases. Orbit (2010) 0.90
Branch retinal arterial occlusion associated with toxoplasmic chorioretinitis. Ocul Immunol Inflamm (2004) 0.90
Diurnal variation of the tear osmolarity in normal subjects measured by a new microchip system. Eur J Ophthalmol (2012) 0.89
Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model. Acta Ophthalmol (2010) 0.89
Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion. Curr Eye Res (2003) 0.89
Perioperative antibiotic prophylaxis and cost in a Turkish University Hospital. Infez Med (2007) 0.88
Aqueous humor and plasma levels of vascular endothelial growth factor and nitric oxide in patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Glaucoma (2010) 0.87
Severe corneal changes following intravitreal injection of bevacizumab. Ocul Immunol Inflamm (2010) 0.87
Amniotic membrane transplantation for treatment of symblepharon in a patient with recessive dystrophic epidermolysis bullosa. Cornea (2006) 0.86
The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol (2006) 0.86
The effect of nicotine on choroidal thickness. Br J Ophthalmol (2013) 0.85
Basosquamous carcinoma of the lacrimal sac: a case report. Orbit (2007) 0.85
Intraocular pressure after phacoemulsification in eyes with pseudoexfoliation. J Cataract Refract Surg (2009) 0.84
The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.84
Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery: surgical and cosmetic outcome. Cornea (2007) 0.84
Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Cornea (2010) 0.82
p53 expression in pterygium in two climatic regions in Turkey. Indian J Ophthalmol (2009) 0.82
Tear clearance measurement in patients with dry eye syndrome using quantitative lacrimal scintigraphy. Ann Nucl Med (2005) 0.82
Evaluation of ocular surface changes in a rabbit dry eye model using a modified impression cytology technique. Curr Eye Res (2007) 0.81
Astigmatism induced by oblique clear corneal incision: right vs. left eyes. Can J Ophthalmol (2007) 0.81
Choroidal thickness changes in patients with migraine. Acta Neurol Belg (2014) 0.81
Vascularization is more delayed in amniotic membrane graft than conjunctival autograft after pterygium excision. Am J Ophthalmol (2006) 0.81
Bilateral synchronous primary orbital lymphoma. Adv Ther (2006) 0.81
Ocular toxoplasmosis presenting as neuroretinitis: report of two cases. Ocul Immunol Inflamm (2002) 0.80
Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis. Cornea (2006) 0.80
The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization. Acta Ophthalmol (2012) 0.79
Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model. Curr Eye Res (2013) 0.79
Effect of corneal thickness on intraocular pressure measurements with the Pascal dynamic contour, Canon TX-10 non-contact and Goldmann applanation tonometers in healthy subjects. Clin Exp Optom (2008) 0.79
Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma. Saudi Med J (2007) 0.78
The effect of caffeine on choroidal thickness in young healthy subjects. Cutan Ocul Toxicol (2014) 0.78
Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model. Acta Ophthalmol Scand (2007) 0.78
The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats. Curr Eye Res (2007) 0.78
Choroidal thickness changes in patients with pseudoexfoliation syndrome. Int Ophthalmol (2014) 0.77
Evaluation of choroidal thickness using spectral-domain optical coherence tomography in patients with migraine: a comparative study. Eur J Ophthalmol (2015) 0.77
Retinal arterial macroaneurysm rupture following fundus fluorescein angiography and treatment with Nd:YAG laser membranectomy. Ophthalmic Surg Lasers Imaging (2007) 0.77
Tear osmolarity in unilateral pseudoexfoliation syndrome. Clin Exp Optom (2012) 0.76
Efficiency of Rarebit perimetry in the evaluation of homonymous hemianopia in stroke patients. Br J Ophthalmol (2007) 0.76
Posterior scleritis in psoriatic arthritis. Retina (2003) 0.76
Choroidal abscess due to nocardial infection in a renal allograft recipient. Retina (2004) 0.76
Retinal and choroidal thickness changes after single anti-VEGF injection in neovascular age-related macular degeneration: ranibizumab vs bevacizumab. Eur J Ophthalmol (2014) 0.76
Astigmatic changes following pterygium removal: comparison of 5 different methods. Indian J Ophthalmol (2013) 0.75
Trypan-blue-assisted capsulorhexis for trainee phacoemulsification surgeons. J Cataract Refract Surg (2003) 0.75
Recurrent iris cyst discharge. J Cataract Refract Surg (2011) 0.75
Impression cytology and ocular surface characteristics in patients with seborrhoeic dermatitis. Acta Ophthalmol (2011) 0.75
INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA. Retina (2017) 0.75
Spontaneous posterior dislocation of both lenses in a patient with Marfan's syndrome: 17 years without complications. Int Ophthalmol (2006) 0.75
Effect of 1- and 6-Hour-Delayed Corneal Collagen Cross-Linking on Corneal Healing in a Rabbit Alkali-Burn Model: Clinical and Histological Observations. Cornea (2016) 0.75
One surgeon's experience with hydrophilic and hydrophobic intraocular lens implantation using the Monarch II injector. Can J Ophthalmol (2008) 0.75
Bilateral corneal infiltrates and uveitis in a pediatric patient with presumed ocular sarcoidosis. Ocul Immunol Inflamm (2013) 0.75
Ethambutol-induced optic neuropathy in a patient with pituitary macroadenoma: case report. Adv Ther (2004) 0.75
Oral anticoagulant therapy, endocapsular hematoma, and neodymium:YAG capsulotomy. J Cataract Refract Surg (2006) 0.75
Repeat LASIK after penetrating keratoplasty for repair of a corneal perforation from previous LASIK. J Refract Surg (2006) 0.75